Macquarie Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-326
Closed -$14.9K 2319
2022
Q2
$13K Hold
326
﹤0.01% 2411
2022
Q1
$258K Hold
326
0.2% 94
2021
Q4
$24K Sell
326
-189
-37% -$15.5K ﹤0.01% 2359
2021
Q3
$47K Buy
+515
New +$43.8K ﹤0.01% 2252

Other funds holding ASTH

Macquarie Group's ASTH Position: Q3 2022 in Review

Macquarie Group sold out of Astrana Health (ASTH) in Q3 2022, closing a stake of 326 shares — an estimated $14.9K sold.

Macquarie Group first reported a position in ASTH in Q3 2021 and held it in 4 quarters. The position peaked at $258K in Q1 2022. 154 funds tracked by Wall St. Rank hold ASTH as of Q3 2022.

  • Macquarie Group reported no remaining Astrana Health position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 326 Astrana Health shares in Q3 2022, an estimated $14.9K.
  • Macquarie Group first reported a position in Astrana Health in Q3 2021 and held it in 4 quarters.
  • Macquarie Group's Astrana Health position peaked at $258K in Q1 2022.
  • 154 funds tracked by Wall St. Rank held Astrana Health as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.